Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 19,602 shares at $85.44 ($1.7M) on 2023-04-21, disclosed to the SEC on 2023-04-25.
Open-market sale of $1.7M TMDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.44 | 8,700 | $743K | 43.2% |
| 2 | $86.09 | 1,300 | $112K | 6.5% |
| 3 | $90.02 | 2,026 | $182K | 10.6% |
| 4 | $90.02 | 2,026 | $182K | 10.6% |
| 5 | $90.04 | 2,775 | $250K | 14.5% |
| 6 | $90.04 | 2,775 |
| $250K |
| 14.5% |
| Total | $87.73 avg | 19,602 | $1.7M | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |